NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/06/2024
Back to search
Official data from USPTO
TRANSCEND THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
08/06/2024
Trademark type
Combined
Nice classes
42
Filing date
08/15/2023
Registration date
08/06/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/06/2024
Last transaction
08/06/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2021-12-00
First use in commerce
2021-12-00
Drawing code
5
Owner type
03
Owner location
New York, NY
Examiner
WILSON, MARYNELLE
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "TRANSCEND" in stylized form with the "R" and adjacent letter "A" connected; the word "THERAPEUTICS" appears below the "TRANSCEND" element, offset to the right, and both word ends are flush.
Holders and representatives
Holders
Transcend Therapeutics, Inc.
Representatives
DEVON E. WHITE WYRICK ROBBINS YATES & PONTON LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
pharmaceutical research and development in the field of neuropsychiatric diseases
Publications
History of USPTO decisions and trademark events.
13 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/21/2024
PUBO
PUBLISHED FOR OPPOSITION
05/21/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/17/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
04/17/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/17/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
04/17/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/17/2024
DOCK
ASSIGNED TO EXAMINER
04/15/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/13/2023
NWAP
NEW APPLICATION ENTERED
08/18/2023
Continuous trademark protection
Get notified about every new filing that threatens TRANSCEND THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.